May 09, 2024

SNDL Smokes Gross Margins with Record Results on Q1 Earnings Report

PRISM Cannabis Index company, SNDL, Inc. (SNDL) announced first quarter record gross margins of 25% with gross profits of $50.4M which was up 17% from a year ago. Additionally, net revenues increased by 4% year-over-year but on a quarterly basis declined by $50.7M, due to seasonality. Operating loss improved greatly at $4.4M compared to $32.2M… [Read More]
Green stock market graph and bar chart price display
May 09, 2024

Quoin Pharmaceuticals Advances on First Quarter Earnings; Clinical Updates

Shares in specialty pharmaceutical company, Quoin Pharmaceuticals (Nasdaq: QNRX) rose in morning trading on Thursday after the company announced its financial results for the first quarter ended March 31, 2024 and provided a business update. “We are pleased to announce this encouraging start to 2024 as throughout the past quarter we successfully built upon the… [Read More]
Magnetic resonance imaging of human brain
May 09, 2024

Acumen Doses First Patient in Alzheimer’s Disease Trial

Acumen Pharmaceuticals (Nasdaq: ABOS) has dosed the first patient in its Phase 2, multi-center, randomized, double-blind, placebo-controlled clinical trial evaluating sabirnetug (ACU193) as a treatment for Alzheimer’s disease (AD). Sabirnetug, a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs), has been granted FDA Fast Track designation and was previously evaluated in a Phase… [Read More]
May 09, 2024

Wall Street Responds to Labor Market Slowdown and Fed Rate Cut Speculations

Wall Street received further indications of a slowing labor market, potentially leading to Federal Reserve rate cuts this year. Equities saw a slight increase after jobless claims rose to their highest level since August, surpassing estimates and prompting traders to increase their bets on policy easing in 2024. In the Treasury market, short-term maturities outperformed,… [Read More]
Disabled woman, going to her parents, through the park.
May 08, 2024

NeuroSense Drug Candidate Slows Disease Progression in ALS

In a potential win for people living with amyotrophic lateral sclerosis (ALS), NeuroSense Therapeutics (Nasdaq: NRSN) has announced that its lead drug candidate, Prime C, has demonstrated a statistically significant slowing of disease progression in high-risk ALS patients in a Phase 2b clinical trial. PrimeC is a novel extended-release oral formulation composed of a unique… [Read More]
May 08, 2024

No Seeds, No Stems, No Sticks. Just Green for Village Farms as They Blaze Through Year- Over-Year Metrics on Earnings

The agricultural greenhouse operator Village Farms International (VFF) announced first quarter financials today, before the open. Q1 EPS ($0.03) vs FactSet ($0.02) but beat on revenue $78.1M vs FactSet $71.4M as well as adjusted EBITDA $3.6M vs FactSet $1.8M. Many positive year-over-year metric improvements were cited as revenues were up 21%, net loss improved by… [Read More]
May 08, 2024

Innodata Reports Stellar First Quarter; Shares Surge 40%

Shares in Innodata (Nasdaq: INOD) soared more than 40% to reach $9.46 in morning trading on Wednesday after the company announced stellar results for the first quarter ended March 31, 2024 on Tuesday. The company announced a revenue increase of 41%, and raised guidance to at least 40% organic revenue growth in 2024, up from… [Read More]